Is Jagsonpal Pharmaceuticals Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Jagsonpal Pharmaceuticals Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Jagsonpal Pharmaceuticals Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Jagsonpal Pharmaceuticals Ltd?

Muslim investors may consider investing in Jagsonpal Pharmaceuticals Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Jagsonpal Pharmaceuticals Ltd classified as HALAL?

Musaffa determines the Shariah status of Jagsonpal Pharmaceuticals Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Jagsonpal Pharmaceuticals Ltd updated?

The Shariah compliance status of Jagsonpal Pharmaceuticals Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Jagsonpal Pharmaceuticals Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Jagsonpal Pharmaceuticals Ltd?

You can check the latest Shariah compliance status of Jagsonpal Pharmaceuticals Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

JAGSNPHARM.NS Shariah Compliance

Screening Methodology: AAOIFI

HALAL

Last Updated: March 05, 2026

Report Source: 2026 3rd Quarter Report

Jagsonpal Pharmaceuticals Ltd. Stock Analysis JAGSNPHARM.NS

India Health Care Micro Cap Report: Q3, 2026

Jagsonpal Pharmaceuticals Ltd. engages in the development and manufacture of intermediate drugs and pharmaceutical formulations. The company is headquartered in Gurgaon, Haryana and currently employs 1,399 full-time employees. The firm is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its Gynaecology products include Divatrone, Endoreg, Cystelia-M, Fibristone, Yuliprist, Deereg, and Lycored Softgel. Its Orthopaedics products include JP Tone Up, Metadec 50 Injection, Metadec 25 Injection, Indocap SR, and Indocap, Colla-2. Its other products include Equirex, Doxypal DR-L, JP Tone Syrup, and Lycored Syrup.

Key Statistics of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

₹205.61₹212.00

Today's Open

₹206.37

Volume

77.03K

P/E Ratio (TTM)

25.74

52 Week Range

₹155.00₹301.65

Market Cap

11.30B

Avg. Volume

225.57K

Dividend Yield

1.17%

Financial Metrics & Statements of Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS)

FAQ's for Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS)

According to Musaffa’s Shariah screening methodology, Jagsonpal Pharmaceuticals Ltd (JAGSNPHARM.NS) is currently classified as HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.